China Shineway Pharmaceutical Group Limited (2877) - Financial and Strategic SWOT Analysis Review

Apr, 2016   |   25  Pages   |   GlobalData   |   Format : PDF

Summary

China Shineway Pharmaceutical Group Limited (China Shineway), a subsidiary of Shineway Pharmaceutical Group Ltd. is a pharmaceutical company that offers therapeutic products. The company develops, manufactures and sells modern Chinese medicine. Its products include shenmai injection, qingkailing injection, huangqi injection, shuxiening injection, wufu xinnaoqing soft capsules, qingkailing soft capsules, coryza soft capsules, vitamin E soft capsules and others. China Shineway provides banlangen granules, ganmao qingre granules, yening granules, cefalexin granules, xiesaitong dripping pills, liuwei dihuang wan, and aspirin tablets. The company's products are used in treatment of coronary heart disease, viral cardiac muscle inflammation, chronic pulmonary heart disease, cardiac cerebrovascular diseases, chronic tonsillitis, pharyngitis, stomatitis and parotitis, and agranulocytosis. China Shineway is headquartered in Wanchai, Hong Kong.

China Shineway Pharmaceutical Group Limited Key Recent Developments

Dec 31, 2015: China Shineway Pharmaceutical Group Resignation Of Executive Director
Oct 23, 2015: China Shineway Pharmaceutical Group Announcement Of Turnover Information
Apr 24, 2015: China Shineway Pharmaceutical Group: Announcement Of Turnover Information For The Three Months Ended 31 March 2015
Mar 27, 2015: China Shineway Pharmaceutical Group: Announcement Of Annual Results For The Year Ended 31 December 2014

This compr

Table of Contents

Section 1 - About the Company

China Shineway Pharmaceutical Group Limited - Key Information
China Shineway Pharmaceutical Group Limited - Overview
China Shineway Pharmaceutical Group Limited - Key Employees
China Shineway Pharmaceutical Group Limited - Key Employee Biographies
China Shineway Pharmaceutical Group Limited - Key Operational Heads
China Shineway Pharmaceutical Group Limited - Major Products and Services
China Shineway Pharmaceutical Group Limited - History
China Shineway Pharmaceutical Group Limited - Company Statement
China Shineway Pharmaceutical Group Limited - Locations And Subsidiaries
China Shineway Pharmaceutical Group Limited - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

China Shineway Pharmaceutical Group Limited - Business Description
China Shineway Pharmaceutical Group Limited - Corporate Strategy
China Shineway Pharmaceutical Group Limited - SWOT Analysis
SWOT Analysis - Overview
China Shineway Pharmaceutical Group Limited - Strengths
China Shineway Pharmaceutical Group Limited - Weaknesses
China Shineway Pharmaceutical Group Limited - Opportunities
China Shineway Pharmaceutical Group Limited - Threats
China Shineway Pharmaceutical Group Limited - Key Competitors

Section 3 - Company Financial Performance Charts

China Shineway Pharmaceutical Group Limited - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company

List of Tables

China Shineway Pharmaceutical Group Limited, Key Information
China Shineway Pharmaceutical Group Limited, Key Ratios
China Shineway Pharmaceutical Group Limited, Share Data
China Shineway Pharmaceutical Group Limited, Major Products and Services
China Shineway Pharmaceutical Group Limited, History
China Shineway Pharmaceutical Group Limited, Key Employees
China Shineway Pharmaceutical Group Limited, Key Employee Biographies
China Shineway Pharmaceutical Group Limited, Key Operational Heads
China Shineway Pharmaceutical Group Limited, Other Locations
China Shineway Pharmaceutical Group Limited, Subsidiaries
China Shineway Pharmaceutical Group Limited, Key Manufacturing facilities
China Shineway Pharmaceutical Group Limited, Key Competitors
China Shineway Pharmaceutical Group Limited, SWOT Analysis
China Shineway Pharmaceutical Group Limited, Ratios based on current share price
China Shineway Pharmaceutical Group Limited, Annual Ratios
China Shineway Pharmaceutical Group Limited, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

China Shineway Pharmaceutical Group Limited, Performance Chart
China Shineway Pharmaceutical Group Limited, Ratio Charts

China Petrochemicals Report
The China Petrochemicals Report has been researched at source, and features BMI Research's market assessment and independent forecasts for key petrochemicals sub-sectors. The report also analyses the impact of regulatory changes, recent developments and the background macroeconomic outlook and featu
China Oil and Gas Report
BMI View: China's long-term crude oil and liquids output will remain on a firm downtrend as low oil prices slowdown exploration and render certain high-cost mature and unconventional plays uneconomic. Outlook is more positive for natural gas, as the government seeks to increase the share of ga
China Pharmaceuticals and Healthcare Report
BMI View: China will become a leading medical research hub within the Asia Pacific region. This will be largely led by multinational pharmaceutical firms as they seek to tap the large talent pool within the country and develop treatments 'in China, for China'. The local industry, while stil
China Telecommunications Report
BMI View: Operator strategies will continue to chime with the government's directive to drive uptake of wireline broadband and machine-to-machine (M2M) connections. However, this means that even as subscription numbers rise, the prices of basic services will be compressed and operators will derive p
Global and China Lithium Carbonate Industry Report, 2016-2020
Driven by a surge in sales volume of new energy vehicles in China, the upstream material- lithium carbonate was in short supply in the fourth quarter of 2015 with soaring prices. Global lithium carbonate output increased by 12.3% year on year to 202,800 tons in 2015 and is expected to arrive at 244,

Select a Licence type

Custom Research

We are known to provide exact requirements. Try our CUSTOM RESEARCH option and get the exact search result you are searching for.

Contact Us

Postal Address:
808, Real Tech Park, 8th Floor, Sector - 30A, Vashi, Navi Mumbai - 400703 , INDIA .
Telephone: +91 22 27810772, 27810773
Email: info@marketreportsonchina.com
Fax Number: +91 22 27812707

Follow Us On: